Inside the Funding Frenzy to Build the Ultimate Robot Hand in China

The Series A round was co-led by Li Auto Strategic Investment (the EV maker's venture arm), CSC Financial Capital, and CSC Investment, with continued participation from existing backers including Xiaomi’s strategic investment unit, Caitong Capital, and CETC Fund . Several new investors joined, including Yangtze River Delta Digital Culture Group and Yuanjia Fund . The speed and the strategic profile of the investors—major automakers, a smartphone giant, and state-backed financial institutions—signal that dexterous hands are no longer a niche R&D curiosity but a supply-chain priority for companies racing to commercialize humanoid robots at scale.

The Product Catalyst: Flex 2 and the Proof of Viability

Xynova’s fundraising acceleration was not just about financial momentum—it was tightly linked to a major product milestone. In mid-May 2026, the company launched the Flex 2, its second-generation dexterous hand, which immediately attracted attention from strategic investors and the broader robotics industry .

The Flex 2 is an ultra-light hybrid hand weighing just 400 grams in the palm while delivering a single-hand payload of 12 kg, 23 total degrees of freedom, and a repeatability of ±0.1 mm . It combines cable-driven actuation with direct-drive motors in a hybrid configuration that allows it to switch between delicate manipulation—holding an egg or a berry without crushing it—and industrial-strength grasping . The hand also integrates multimodal sensing with real-time slip detection, a force control resolution of 0.05 N, and a rated 4 kg continuous load .

The launch was timed to coincide with the world’s largest robotics conference, ICRA 2026, and gave Xynova the visibility it needed to attract Xiaomi’s deepening involvement. Xiaomi had already participated in the company’s angel-stage financing, but after the Flex 2 reveal, Xiaomi Strategic Investment doubled down as an existing shareholder in the Series A . Public reports note that Xiaomi is building its own humanoid robot platform and that Xynova’s hands are a natural target for integration . The funding round will partially fund the establishment of formal production capacity: by the end of 2026, Xynova aims to produce 10,000 dexterous hands and 200,000 miniature electric cylinders annually .

The Broader Arms Race: Linkerbot and the $6 Billion Target

Xynova is not operating in a vacuum. Beijing-based Linkerbot, which commands more than 80% of the global market for high-degree-of-freedom dexterous hands by volume, completed its own Series B+ round in early May 2026 and is already targeting a valuation of $6 billion in its next raise—double what it achieved in the just-closed round . Linkerbot’s investors include Alibaba’s Ant Group, Sequoia spin-off HongShan Group, Zhongguancun Science Park Fund, Bank of China Asset Management, and Fosun Capital .

Linkerbot’s position reflects the extreme concentration that makes this race so high-stakes. It is reportedly the only company in the world producing more than 1,000 high-DoF dexterous hands per month, and its co-founder has predicted that per-unit costs could fall below ¥500 (roughly $70) within three years as production scales . If that projection holds, dexterous hands will move from an expensive bottleneck to a cheap, commoditized component—and the companies that own the supply chains today will dominate the humanoid robot market of the late 2020s.

Why Dexterous Hands Are Attracting Strategic Capital

The flood of capital makes strategic sense when viewed through the lens of the broader humanoid robotics ecosystem. While legs continue to improve thanks to advances in proprioceptive actuation and reinforcement learning, manipulation remains the harder and more valuable problem. A humanoid robot that can walk but not reliably screw on a bottle cap, fold a shirt, or use tools will never graduate from demonstration videos to factories and homes.

That is why major OEMs and battery manufacturers are appearing on Xynova’s cap table. Xiaomi’s involvement reflects a direct interest in integrating dexterous manipulation into its own CyberOne humanoid platform, while Li Auto’s participation suggests a similar interest in robotic manufacturing and logistics . CATL, the global battery leader, led Xynova’s angel round, indicating that even companies not typically associated with robotics are positioning themselves as component-level investors in the humanoid supply stack .

Beyond Xynova and Linkerbot, the broader robotics sector has seen a cascade of major investments. Galbot, an embodied AI robot developer, raised 2.5 billion yuan (roughly $350 million) in March 2026, with participation from China’s national AI investment fund . Inspire Robots closed back-to-back Series C rounds in early 2026 from investors including Shenzhen Capital Group and Qiming Venture Partners . And in December 2025 alone, China’s robotics sector saw 36 disclosed financing deals collectively approaching 10 billion yuan .

The Stakes

The “arms race” framing captures the reality that this is not a market for dozens of differentiated winners. Dexterous robotic hands are a complex integration problem—combining miniature motors, sensors, tendon-routing, force-controlled electronics, and AI-driven grasping policies into a single end-effector—and the first movers to hit cost and reliability targets at scale will likely consolidate enormous share.

For the investors writing hundred-million-yuan checks, the bet is that the hand is the last piece of the hardware puzzle. If they can own the dexterity layer, they will own the gateway through which every humanoid robot must pass.